Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of BGB-A1217 in Combination With Tislelizumab in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04047862
Recruitment Status : Recruiting
First Posted : August 7, 2019
Last Update Posted : September 26, 2019
Sponsor:
Information provided by (Responsible Party):
BeiGene

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 5, 2021
Estimated Study Completion Date : April 5, 2021